The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your ...

Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.

A new publication reveals breakthrough results in GLP-1 obesity management using Ivim Health's individualized virtual integrative medicine (IVIM) protocol ...

New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...

Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...

A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Harvard T.H. Chan School of Public Health suggests combining GLP-1 weight-loss medication with tailored nutrition and ...

The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...